Explore more profound levels of insights and perspectives from Omada.
What does the evidence say about GLP-1 efficacy for weight loss? Omada answers frequently asked questions from benefit plan managers and payers as they navigate the use of GLP-1s for weight loss.
Read White paper
Read White paper
In this paper, we’ll lay out our view on what customers should look for and what questions they should ask when evaluating digital health offerings.
Read White paper
As employers assess the ROI of diabetes prevention programs, new analysis shows that focusing on weight loss may be obscuring the real sources of value.
Read White paper
Through a uniquely personal virtual-first care model, Omada’s dedicated care teams across all of our programs—Prevention, Hypertension, Diabetes, and Musculoskeletal.
Read White paper
In the growing market for virtual care, Omada Health has continued to deliver proven health outcomes and ROI for its customers. Now with the Omada Insights Lab, the company unveils the interdisciplina
Read White paper
A new analysis from Omada Insights Lab shows that changing patients’ mindsets is a critical factor in improving behavior and health outcomes in diabetes prevention
Read White paper
Read White paper
Read White paper
Read White paper
Virtual health was on the rise well before the pandemic. But COVID-19 has caused it to skyrocket—fundamentally changing the way patients access healthcare services, and how & where providers practice
Read White paper
Omada + Abbott have partnered to help people with diabetes manage their condition more safely, easily, and conveniently, thanks to continuous glucose monitoring (CGM) technology.
Read White paper
Access to care has gotten harder: Now more than ever, your employees demand solutions that treat them holistically and digitally given the difficulty of accessing in-person healthcare.
Read White paper
Read White paper
Read White paper
Read White paper
Read White paper
Read White paper
Read White paper
Read White paper
Loading More...
